Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified

Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified — Trials · CancerIndex

Clinical trials

Registered studies

46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Jacqueline Garcia, MD
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03878524	Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial	terminated	Phase 1	2	OHSU Knight Cancer InstituteOTHER	1	Mar 4, 2024	clinicaltrials
NCT00039091	Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer	terminated	Phase 1	26	National Cancer Institute (NCI)NIH	1	Sep 5, 2018